TCA
MEDP icon

Transcend Capital Advisors’s Medpace MEDP Stock Holding History

Transcend Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Sell
907
-375
-29% -$192K 0.03% 415
2025
Q4 		$720K Buy
1,282
+335
+35% +$190K 0.06% 300
2025
Q3 		$487K Buy
+947
New +$413K 0.03% 377

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Transcend Capital Advisors's MEDP Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Medpace (MEDP) stake by 29% in Q1 2026, selling an estimated $192K and leaving 907 shares worth $436K. The position accounts for 0.03% of the portfolio, ranked #415.

Transcend Capital Advisors first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $720K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Transcend Capital Advisors held 907 shares of Medpace worth $436K as of Q1 2026.
  • Transcend Capital Advisors sold 375 Medpace shares in Q1 2026, an estimated $192K.
  • Medpace made up 0.03% of Transcend Capital Advisors's portfolio in Q1 2026, its #415 holding.
  • Transcend Capital Advisors first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Transcend Capital Advisors's Medpace position peaked at $720K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.